All Stories

  1. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants

    Article • Journal of Thrombosis and Haemostasis, April 2018, Wiley

    Dr GUALTIERO PALARETI, B C, Dr Emilia Antonucci

  2. Epidemiology, diagnosis, and management of atrial fibrillation in women

    Article • International Journal of Women s Health, June 2015, Dove Medical Press

    Dr Emilia Antonucci

  3. The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

    Article • PLoS ONE, May 2015, PLOS

    Dr Emilia Antonucci

  4. Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity

    Article • Thrombosis Research, September 2014, Elsevier

    Dr Emilia Antonucci

  5. A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin

    Article • Internal and Emergency Medicine, March 2014, Springer Science + Business Media

    Dr Emilia Antonucci

  6. Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity

    Article • Journal of Thrombosis and Thrombolysis, August 2013, Springer Science + Business Media

    Dr Emilia Antonucci

  7. Gender differences of bleeding and stroke risk in very Old atrial fibrillation patients on VKA treatment

    Article • Thrombosis Research, January 2013, Elsevier

    Dr Emilia Antonucci

  8. Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion

    Article • Thrombosis Research, May 2012, Elsevier

    Dr Emilia Antonucci

  9. Bleeding and Stroke Risk in a Real-world Prospective Primary Prevention Cohort of Patients With Atrial Fibrillation

    Article • CHEST Journal, October 2011, Elsevier

    Dr Emilia Antonucci

  10. Light Transmittance Aggregometry Induced by Different Concentrations of Adenosine Diphosphate to Monitor Clopidogrel Therapy: A Methodological Study

    Article • Therapeutic Drug Monitoring, February 2011, Wolters Kluwer Health

    Dr Emilia Antonucci

  11. Stroke Risk Stratification in a “Real-World” Elderly Anticoagulated Atrial Fibrillation Population

    Article • Journal of Cardiovascular Electrophysiology, January 2011, Wiley

    Dr Emilia Antonucci

  12. Bleeding Risk During Oral Anticoagulation in Atrial Fibrillation Patients Older Than 80 Years

    Article • Journal of the American College of Cardiology, September 2009, Elsevier

    Dr Emilia Antonucci

  13. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients

    Article • International Journal of Cardiology, February 2009, Elsevier

    Dr Emilia Antonucci

  14. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention

    Article • Thrombosis and Haemostasis, January 2009, Schattauer GmbH

    Dr Emilia Antonucci

  15. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment

    Article • Thrombosis and Haemostasis, January 2009, Schattauer GmbH

    Dr Emilia Antonucci

  16. Assessment of Fibrinolytic Activity by Measuring the Lysis Time of a Tissue Factor-induced Clot: A Feasibility Evaluation

    Article • Clinical and Applied Thrombosis/Hemostasis, December 2008, SAGE Publications

    Dr Emilia Antonucci

  17. Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy

    Article • Thrombosis and Haemostasis, October 2007, Schattauer GmbH

    Dr Emilia Antonucci

  18. Comparison of Different Methods to Evaluate the Effect of Aspirin on Platelet Function in High-Risk Patients With Ischemic Heart Disease Receiving Dual Antiplatelet Treatment

    Article • American Journal of Clinical Pathology, July 2007, Oxford University Press (OUP)

    Dr Emilia Antonucci

  19. Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS2 score

    Article • Thrombosis Research, January 2007, Elsevier

    Dr Emilia Antonucci

  20. Usefulness of Aspirin Resistance After Percutaneous Coronary Intervention for Acute Myocardial Infarction in Predicting One-Year Major Adverse Coronary Events

    Article • The American Journal of Cardiology, November 2006, Elsevier

    Dr Emilia Antonucci

  21. Hyperviscosity as a Possible Risk Factor for Cerebral Ischemic Complications in Atrial Fibrillation Patients

    Article • The American Journal of Cardiology, June 2006, Elsevier

    Dr Emilia Antonucci

  22. Anticoagulation Intensity and Stroke During Warfarin-Use in Atrial Fibrillation Patients * Response:

    Article • Stroke, January 2006, Wolters Kluwer Health

    Dr Emilia Antonucci

  23. TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit

    Article • Thrombosis Research, January 2006, Elsevier

    Dr Emilia Antonucci

  24. We-P11:227 Hyperviscosity as a possible risk factor for cerebral ischemic complications in nonvalvular atrial fibrillation patients

    Article • Atherosclerosis Supplements, January 2006, Elsevier

    Dr Emilia Antonucci

  25. Hyperhomocysteinemia and vitamin B6 deficiency: New risk markers for nonvalvular atrial fibrillation?

    Article • American Heart Journal, September 2004, Elsevier

    Dr Emilia Antonucci

  26. Clotting activation after oral anticoagulant therapy discontinuation

    Article • Blood Coagulation & Fibrinolysis, April 2004, Wolters Kluwer Health

    Dr Emilia Antonucci

  27. Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism

    Article • Thrombosis and Haemostasis, September 2003, Schattauer GmbH

    Dr Emilia Antonucci

  28. Asymptomatic excessive coumarin anticoagulation is a risk factor for thrombotic and bleeding complications of oral anticoagulant therapy

    Article • Journal of Thrombosis and Haemostasis, August 2003, Wiley

    Dr Emilia Antonucci

  29. Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic

    Article • Blood Coagulation & Fibrinolysis, April 2003, Wolters Kluwer Health

    Dr Emilia Antonucci

  30. High prevalence of ACE DD and genotype in patients with atrial fibrillation

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Dr Emilia Antonucci

  31. Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination

    Article • Blood Coagulation & Fibrinolysis, June 2002, Wolters Kluwer Health

    Dr Emilia Antonucci

  32. PERSISTENCE OF HEMOSTATIC ALTERATIONS IN PATIENTS AFFECTED BY CROHN'S DISEASE AFTER BOWEL SURGERY

    Article • Thrombosis Research, September 1997, Elsevier

    Dr Emilia Antonucci